Orbsen Therapeutics' Unattributed Round

Orbsen Therapeutics raised a round of funding on July 26, 2017.

Orbsen Therapeutics, fka Pro-Cure Laboratories, is a regenerative medicine company that is developing stromal cell treatments to address a wide range of medical conditions including heart disease, art…

Articles about Orbsen Therapeutics' Unattributed Round: